Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-09-15
2009-06-09
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S023000, C514S210010, C514S210020, C514S376000, C514S379000, C514S461000, C536S004100, C548S952000
Reexamination Certificate
active
07544667
ABSTRACT:
The present invention relates to novel hypocholesterolemic compounds of formula (I) useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels as well as to pharmaceutical compositions comprising said compounds alone or in combination with other active agents.
REFERENCES:
patent: 5306817 (1994-04-01), Thiruvengadam et al.
patent: 5631365 (1997-05-01), Rosenblum et al.
patent: 5633246 (1997-05-01), McKittrick et al.
patent: 5756470 (1998-05-01), Yumibe et al.
patent: 6593078 (2003-07-01), Altmann et al.
patent: 2003/0105028 (2003-06-01), Ghosal et al.
patent: 2003/0119428 (2003-06-01), Davis et al.
patent: 2003/0119809 (2003-06-01), Davis et al.
patent: 3620467 (1987-01-01), None
patent: WO 97/16455 (1997-05-01), None
STN abstract of Van Heek et al. (Journal of Pharmacology and Experimental Therapeutics (1997), 283(1), pp. 157-163) (Abstract Sent).
Rosenblum et al. (Journal of Medicinal Chemistry (1998) 41, pp. 973-980).
Dugar et al. Bioorganic & Medicinal Chemistry Letters (1995), 5(24), 2947-52 (Abstract Sent).
Mukerjee, Arya K. et al., “Rapid Synthesis of Dehydropeptides Carrying a β Lactam Moiety,” J. Chem. Research (S), 1993, pp. 280-281, No. 7, London, Great Britain.
Van Heek, Margaret et al., “In vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor . . . ” JPET, 1997, pp. 157-163, vol. 283, No. 1.
Wu, George Guangzhong, “A Concise Asymmetric Synthesis of a β-Lactam-Based Cholesterol Absorption Inhibitor,” Organic Process Research & Development, 2000, pp. 298-300, vol. 4.
Udupi, R. H. et al., “Synthesis of 1-(2′-carboxy-5′-nitrophenyl)-3,4-substituted azetidin-2-ones . . . ” Indian Journal of Heterocyclic Chem., Oct.-Dec. 1996, pp. 99-102, vol. 6.
Clader, John W. et al., “2-Azetidinone Cholesterol Absorption Inhibitors: Structure-Activity Relationships . . . ” J. Med. Chem., 1996, pp. 3684-3693, vol. 39, No. 19.
Otto, Hans-Hartwig et al., “Stereochemie der Dehydratisierung und Halogenierung der αR* . . . ” Liebigs Ann. Chem., 1983, pp. 1162-1168, Verlag Chemie GmbH, Weinheim, Germany.
Browne, Margaret et al., “Trans Diastereoselective Synthesis of 3-Alkyl Substituted β-Lactams via the Acid . . . ” Tetrahedron Letters, 1995, pp. 2555-2558, vol. 36, No. 15.
Bose, Ajay K. et al., “Microwave-Assisted Rapid Synthesis of α-Amino-β-Lactams . . . ” Tetrahedron Letters, 1996, pp. 6989-6992, vol. 37, No. 39.
Van Leusen, Albert M. et al., “Base-Induced Cycloaddition of Sulfonylmethyl Isocyanides to C,N Double Bonds . . . ” J. Org. Chem., 1977, pp. 1153-1159, vol. 42, No. 7.
Burnett, Duane A. et al., “Synthesis of 3-(1-Hydroxyethyl)-2-azetidinones via Ester-Imine Condensations,” J. Org. Chem., 1985, pp. 5120-5123, vol. 50, No. 25.
Burnett, Duane A. et al., “2-Azetidinones as Inhibitors of Cholesterol Absorption,” Journal of Medicinal Chemistry, Jun. 10, 1994, pp. 1733-1736, vol. 37, No. 12.
Rosenblum, Stuart B. et al., “Synthesis of 3-Arylpropenyl, 3-Arylpropynyl and 3-Arylpropyl 2-Azetidinones as Cholesterol Absorption . . . ” Tetrahedron, 2000, pp. 5735-5742, vol. 56.
Kirkup, Michael P. et al., “(-)-SCH 57939: Synthesis and Pharmacological Properties of a Potent, Metabolically . . . ” Bioorg. Med. Chem. Lett., 1996, pp. 2069-2072, vol. 6, No. 17.
Otto, Hans-Hartwig et al., “Darstellung und Stereochemie von 3-(α-Hydroxybenzyl)-1,4-diphenyl . . . ” Liebigs Ann. Chem., 1983, pp. 1152-1161, Verlag Chemie GmbH, Weinheim, Germany.
Rosenblum, Stuart B. et al., “Discovery of 1-(4-Fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S) . . . ” J. Med. Chem., 1998, pp. 973-980, vol. 41, No. 6.
Burnett, Duane A. et al., “Synthesis of Fluorescent Biochemical Tools Related to the 2-Azetidinone Class . . . ” Bioorg. Med. Chem. Lett., 2002, pp. 315-318, vol. 12, No. 3.
Burnett, Duane A. et al., “Synthesis of Iodinated Biochemical Tools Related to the 2-Azetidinone Class . . . ” Bioorg. Med. Chem. Lett., 2002, pp. 311-314, vol. 12, No. 3.
Carreira Erick
Hauser Helmut
Kvaerno Lisbet
Ritter Tobias
Werder Moritz
Henry Michael C
Jiang Shaojia Anna
Lipideon Biotechnology AG
The Webb Law Firm
LandOfFree
Hypocholesterolemic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypocholesterolemic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypocholesterolemic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4090991